GROUPAMA ASSET MANAGMENT

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1055969 PARIS, I0

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$48,598,707

-$6,337,542 QoQ

Shares Held

77,940

+9.6% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

#126

of 1,322 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 85% Shared 0% None 15%

Healthcare · as of Jun 30, 2026

GROUPAMA ASSET MANAGMENT holds $277,486,304 across 10 Biotechnology names. REGN ranks #3 (17.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	188,156	$93,462,729
2	IONS	Ionis Pharmaceuticals Inc	937,083	$74,301,311
3	REGN	Regeneron Pharmaceuticals, Inc. This page	77,940	$48,598,707
4	BNTX	BioNTech SE	184,775	$17,193,313
5	MDGL	Madrigal Pharmaceuticals, Inc.	30,941	$16,613,769
6	ALNY	Alnylam Pharmaceuticals, Inc.	34,252	$10,310,879
7	INCY	Incyte Corp	86,423	$9,796,911
8	DNLI	Denali Therapeutics Inc.	229,939	$5,914,031

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,598,707	77,940	+9.6%	Shares	Sole	2026-08-14
2026-03-31	$54,936,249	71,102	-0.1%	Shares	Sole	2026-05-22
2025-12-31	$54,943,250	71,182	+13.5%	Shares	Sole	2026-02-27
2025-09-30	$35,254,891	62,701	-7.6%	Shares	Sole	2025-12-01
2025-06-30	$35,631,750	67,870	-25.1%	Shares	Sole	2025-08-13
2025-03-31	$57,468,848	90,612	+12.8%	Shares	Sole	2025-05-14
2024-12-31	$57,227,879	80,339	+12.7%	Shares	Sole	2025-02-12
2024-09-30	$74,929,233	71,277	+7.0%	Shares	Sole	2024-11-15
2024-06-30	$70,029,077	66,629	+32.7%	Shares	Sole	2024-08-14
2024-03-31	$48,328,547	50,212	-25.5%	Shares	Sole	2024-05-14
2023-12-31	$59,171,275	67,371	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.